1. Home
  2. KRRO vs WHF Comparison

KRRO vs WHF Comparison

Compare KRRO & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • WHF
  • Stock Information
  • Founded
  • KRRO 2014
  • WHF 2011
  • Country
  • KRRO United States
  • WHF United States
  • Employees
  • KRRO N/A
  • WHF N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • WHF Finance Companies
  • Sector
  • KRRO Health Care
  • WHF Finance
  • Exchange
  • KRRO Nasdaq
  • WHF Nasdaq
  • Market Cap
  • KRRO 209.6M
  • WHF 226.2M
  • IPO Year
  • KRRO 2019
  • WHF 2012
  • Fundamental
  • Price
  • KRRO $13.90
  • WHF $9.73
  • Analyst Decision
  • KRRO Strong Buy
  • WHF Sell
  • Analyst Count
  • KRRO 7
  • WHF 4
  • Target Price
  • KRRO $106.33
  • WHF $10.83
  • AVG Volume (30 Days)
  • KRRO 110.5K
  • WHF 130.5K
  • Earning Date
  • KRRO 05-13-2025
  • WHF 05-07-2025
  • Dividend Yield
  • KRRO N/A
  • WHF 15.84%
  • EPS Growth
  • KRRO N/A
  • WHF N/A
  • EPS
  • KRRO N/A
  • WHF 0.47
  • Revenue
  • KRRO $2,271,000.00
  • WHF $92,817,000.00
  • Revenue This Year
  • KRRO N/A
  • WHF N/A
  • Revenue Next Year
  • KRRO $20.00
  • WHF N/A
  • P/E Ratio
  • KRRO N/A
  • WHF $20.84
  • Revenue Growth
  • KRRO N/A
  • WHF N/A
  • 52 Week Low
  • KRRO $11.13
  • WHF $8.44
  • 52 Week High
  • KRRO $98.00
  • WHF $13.44
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 34.42
  • WHF 54.38
  • Support Level
  • KRRO $12.21
  • WHF $8.44
  • Resistance Level
  • KRRO $15.30
  • WHF $9.20
  • Average True Range (ATR)
  • KRRO 2.09
  • WHF 0.35
  • MACD
  • KRRO 0.21
  • WHF 0.09
  • Stochastic Oscillator
  • KRRO 38.74
  • WHF 94.85

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.

Share on Social Networks: